COVID-19 and fungal infections: Etiopathogenesis and therapeutic implications

Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):72-75. doi: 10.37201/req/s01.21.2021. Epub 2021 Sep 30.

Abstract

Invasive fungal infection often complicates patients with severe viral infection, especially those admitted to critical care units. Severe SARS-CoV-2 infection has been no exception and a significant association with Aspergillus spp. has been documented, resulting in high patient mortality. In this summary we describe the clinical presentation, the underlying diseases most commonly linked with this association, radiological manifestations and therapeutic management of CAPA.

Publication types

  • Review

MeSH terms

  • Aspergillus
  • COVID-19*
  • Humans
  • Intensive Care Units
  • Mycoses* / drug therapy
  • SARS-CoV-2